Literature DB >> 33398573

Laparoscopic pancreaticoduodenectomy reduces incidence of clinically relevant postoperative pancreatic fistula in soft pancreas with a smaller than 2 mm pancreatic duct.

Jae Uk Chong1, Seung Soo Hong2,3, Ho Kyoung Hwang2,3, Woo Jung Lee2,3, Chang Moo Kang4,5.   

Abstract

BACKGROUND: Soft pancreas with small pancreatic duct is a known risk factor for postoperative pancreatic fistula (POPF). This study demonstrated the safety and feasibility of laparoscopic duct-to-mucosa pancreaticojejunostomy (PJ) and compared perioperative outcomes of laparoscopic pancreaticoduodenectomy (LPD) and open pancreaticoduodenectomy (OPD) in patients with soft pancreas and small pancreatic duct.
METHODS: From January 2014 to December 2019, 183 patients underwent LPD and 91 patients underwent OPD by a single surgeon. Data on patients with soft pancreas and combined small pancreatic duct (≤ 2 mm) were retrospectively reviewed. Clinicopathologic characteristics, and perioperative outcomes were compared between LPD and OPD. We evaluated risk factors affecting clinically relevant POPF (CR-POPF). We also correlated calculated risks of POPF and CR-POPF between the two groups.
RESULTS: We compared 62 patients in the LPD group and 34 patients in the OPD group. Perioperative outcomes showed less blood loss, shorter hospital stays, and less postoperative pain score on postoperative day (POD)#1 and #5 in LPD compared with OPD. Postoperative complications showed no differences between LPD and OPD. LPD group showed significantly reduced CR-POPF rates compared to the OPD group (LPD 11.3% vs. OPD 29.4%, p = 0.026). Multivariate analysis identified obesity (BMI ≥ 25), thick pancreas parenchyma and open surgery as independent predicting factors for CR-POPF. The LPD group showed less CR-POPF than the OPD group according to POPF risk groups. This difference was more prominent in a high-risk group.
CONCLUSION: With appropriate laparoscopic technique, LPD is feasible and safe and reduces CR-POPF in soft pancreas with a small pancreatic duct.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC part of Springer Nature.

Entities:  

Keywords:  Laparoscopic; Pancreatic fistulas; Pancreaticoduodenectomy; Pancreaticojejunostomy; Small pancreatic duct; Soft pancreas

Mesh:

Year:  2021        PMID: 33398573     DOI: 10.1007/s00464-020-08226-8

Source DB:  PubMed          Journal:  Surg Endosc        ISSN: 0930-2794            Impact factor:   4.584


  3 in total

1.  Long-term natural history after endoscopic resection for gastric dysplasia.

Authors:  Jue Lie Kim; Sang Gyun Kim; Ayoung Lee; Jinju Choi; Hyunsoo Chung; Soo-Jeong Cho
Journal:  Surg Endosc       Date:  2020-09-28       Impact factor: 4.584

  3 in total
  3 in total

1.  Which one is better? Laparoscopic versus robotic reconstruction in the remnant soft pancreas with a small pancreatic duct following pancreaticoduodenectomy: a multicenter study with propensity score matching analysis.

Authors:  Jae Young Jang; Chang Moo Kang; Hyeyeon Kim; Munseok Choi; Jae Hoon Lee; Sung Hoon Choi
Journal:  Surg Endosc       Date:  2022-09-12       Impact factor: 3.453

2.  The usefulness of preoperative exocrine function evaluated by the 13C-trioctanoin breath test as a significant physiological predictor of pancreatic fistula after pancreaticoduodenectomy.

Authors:  Hiroyuki Kato; Yukio Asano; Masahiro Ito; Norihiko Kawabe; Satoshi Arakawa; Masahiro Shimura; Daisuke Koike; Chihiro Hayashi; Kenshiro Kamio; Toki Kawai; Takayuki Ochi; Hironobu Yasuoka; Takahiko Higashiguchi; Daisuke Tochii; Yuka Kondo; Hidetoshi Nagata; Toshiaki Utsumi; Akihiko Horiguchi
Journal:  BMC Surg       Date:  2022-02-11       Impact factor: 2.102

3.  Feasibility of robotic-assisted pancreatic resection in patients with previous minor abdominal surgeries: a single-center experience of the first three years.

Authors:  Paul Viktor Ritschl; Hannah Kristin Miller; Karl Hillebrandt; Lea Timmermann; Matthäus Felsenstein; Christian Benzing; Brigitta Globke; Robert Öllinger; Wenzel Schöning; Moritz Schmelzle; Johann Pratschke; Thomas Malinka
Journal:  BMC Surg       Date:  2022-03-04       Impact factor: 2.102

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.